Evidence map›Paper›PMID 21562307›Full record

ArticleAmerican journal of physiology. Cell physiology2011

Activation of P2Y receptors causes strong and persistent shrinkage of C11-MDCK renal epithelial cells.

Svetlana V Koltsova, Alexandra Platonova, Georgy V Maksimov, Alexander A Mongin, Ryszard Grygorczyk, Sergei N Orlov

Open access · greenAbstract read
In one paragraph

Article in American journal of physiology. Cell physiology, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
1.6field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 9 citations in OpenAlex.

  1. Salt and osmosensing: role of cytoplasmic hydrogel.Pflugers Archiv : European journal of physiology · 2015
    Review
  2. Article
  3. Review
  4. Article
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 4 institutions in 3 countries.

Svetlana V KoltsovaResearch Centre, Centre Hospitalier de l’Université de Montréal (CRCHUM), Montreal, Quebec, Canada.
Alexandra Platonova
Georgy V Maksimov
Alexander A Mongin
Ryszard Grygorczyk
Sergei N Orlov
Centre Hospitalier de l’Université de Montréal · CALomonosov Moscow State University · RUAlbany Medical Center Hospital · USResearch Institute of General Pathology and Pathophysiology, the Russian Academy of Medical Sciences · RU

Funding

Oxidative Stress and Pathological Glutamate Release in StrokeR01NS061953 · NINDS · ALBANY MEDICAL COLLEGE · PI MONGIN, ALEXANDER A · 2009 to 2013
$1.6M
NINDS NIH HHS NS061953NINDS NIH HHS R01 NS061953
6 · The paper itself

Abstract

Purinergic receptors activate diverse signaling cascades and regulate the activity of cell volume-sensitive ion transporters. However, the effects of ATP and other agonists of P2 receptors on cell volume dynamics are only scarcely studied. In the present work, we used the recently developed dual-image surface reconstruction technique to explore the influence of purinergic agonists on cell volume in the C11-Madin-Darby canine kidney cell line resembling intercalated cells from kidney collecting ducts. Unexpectedly, we found that ATP and UTP triggered very robust (55-60%) cell shrinkage that lasted up to 2 h after agonist washout. Purinergic regulation of cell volume required increases in intracellular Ca(2+) and could be partially mimicked by the Ca(2+)-ionophore ionomycin or activation of protein kinase C by 4β-phorbol 12-myristate 13-acetate. Cell shrinkage was accompanied by strong reductions in intracellular K(+) and Cl(-) content measured using steady-state (86)Rb(+) and (36)Cl(-) distribution. Both shrinkage and ion efflux in ATP-treated cells were prevented by the anion channel blocker 5-nitro-2-(3-phenylpropylamino)benzoic acid (NPPB) and by the BK(Ca) channel inhibitors charybdotoxin, iberiotoxin, and paxilline. To evaluate the significance of cell-volume changes in purinergic signaling, we measured the impact of ATP on the expression of the immediate-early gene c-Fos. Thirty-minute treatment with ATP increased c-Fos immunoreactivity by approximately fivefold, an effect that was strongly inhibited by charybdotoxin and completely prevented by NPPB. Overall, our findings suggest that ATP-induced cell-volume changes are partially responsible for the physiological actions of purinergic agonists.

Indexed as

Cell SizeAdenosine TriphosphateAnimalsCalcium SignalingCell LineChloridesCyclic AMP-Dependent Protein KinasesDogsEnzyme ActivationEnzyme ActivatorsEpithelial CellsIonophoresKidneyLarge-Conductance Calcium-Activated Potassium ChannelsPotassiumPotassium Channel BlockersAdenosine TriphosphateChloridesCyclic AMP-Dependent Protein KinasesEnzyme ActivatorsIonophoresLarge-Conductance Calcium-Activated Potassium ChannelsPotassiumPotassium Channel BlockersProtein Kinase CProto-Oncogene Proteins c-fosPurinergic P2Y Receptor AgonistsPurinergic P2Y Receptor AntagonistsReceptors, Purinergic P2YUridine Triphosphate

Identifiers

PMID21562307
PMCPMC3154546
OpenAlexW2165547007

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.